Page last updated: 2024-09-02

fingolimod hydrochloride and 4-deoxypyridoxine

fingolimod hydrochloride has been researched along with 4-deoxypyridoxine in 1 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (4-deoxypyridoxine)	Trials (4-deoxypyridoxine)	Recent Studies (post-2010) (4-deoxypyridoxine)
2,771	157	2,062	53	1	4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gräler, MH; Hemdan, NY; Reimann, CM; Weigel, C	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and 4-deoxypyridoxine

Article	Year
Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. European journal of immunology, 2016, Volume: 46, Issue:12 Topics: Animals; Capillary Permeability; Cells, Cultured; Cytokines; Fingolimod Hydrochloride; Immunomodulation; Lysophospholipids; Membrane Proteins; Mice; Mice, Inbred C57BL; Phosphoric Monoester Hydrolases; Pyridoxine; Receptors, Lysosphingolipid; Sepsis; Signal Transduction; Sphingosine; Vascular Endothelial Growth Factor A	2016

Article

Year

Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis.

European journal of immunology, 2016, Volume: 46, Issue:12

Topics: Animals; Capillary Permeability; Cells, Cultured; Cytokines; Fingolimod Hydrochloride; Immunomodulation; Lysophospholipids; Membrane Proteins; Mice; Mice, Inbred C57BL; Phosphoric Monoester Hydrolases; Pyridoxine; Receptors, Lysosphingolipid; Sepsis; Signal Transduction; Sphingosine; Vascular Endothelial Growth Factor A

2016